At the news
? NEUTRALIMPACT 4/10 CLUSTER filed Feb 23, 2026 at 19:00 ET
Multiple C-suite executives at Caribou Biosciences (CRBU) sold shares in a coordinated cluster over a 7-day window, totaling approximately $35,500 in sales. On the same dates, these insiders also received substantial stock awards (totaling hundreds of thousands of shares), indicating the sales were part of pre-arranged 10b5-1 plans or compensation-related exercises. The activity aligns with recent insider selling trends and appears routine rather than reactive to material non-public information.
- Four C-suite executives sold shares on February 24, 2026, at $1.96 per share, totaling $35,454.44 in aggregate.
- On February 20, 2026, the same executives received stock awards ranging from 45,000 to 55,000 shares, valued at zero because they are newly granted.
- The sales are likely part of pre-scheduled 10b5-1 plans or option exercises tied to compensation, not discretionary market timing.
- Total value of insider sales in the last 30 days is $35K, consistent with this cluster.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access